[1] Etters, L., Goodall, D., & Harrison, B. E. (2008). Caregiver burden among dementia patient caregivers: A review of the literature. Journal of the American Academy of Nurse Practitioners, 20(8), 423–428.

[2] Lovrečič, B., Jelenc, M., Korošec, A., Vidovič, M., & Lovrečič, M. (2020). The prevalence of dementia in Europe and in Slovenia: The review and estimate of dementia for Slovenia for 2018 and projection for 2030. Collegium Antropologicum, 44(1), 55–60.

[3] Cao, Q., Tan, C. C., Xu, W., Hu, H., Cao, X. P., Dong, Q., Tan, L., & Yu, J. T. (2020). The Prevalence of Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease: JAD, 73(3), 1157–1166.

[4] Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., ... & Liu, X. (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, 7(2), e105-e125.

[5] Wolters, F. J., Chibnik, L. B., Waziry, R., Anderson, R., Berr, C., Beiser, A., ... & Hofman, A. (2020). Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. Neurology, 95(5), e519-e531.

[6] Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. (2019). World Health Organization.

[7] Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., ... & Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446.

[8] Tisher, A., & Salardini, A. (2019). A Comprehensive Update on Treatment of Dementia. Seminars in Neurology, 39(2), 167–178.

[9] Sadowsky, C. H., & Galvin, J. E. (2012). Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine, 25(3), 350–366. 

[10] Thomas, P., Lalloué, F., Preux, P. M., Hazif-Thomas, C., Pariel, S., Inscale, R., … Clément, J. P. (2006). Dementia patients caregivers quality of life: The PIXEL study. International Journal of Geriatric Psychiatry, 21(1), 50–56.

[11] Fessel, J. (2020). The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia. Alzheimer’s and Dementia: Translational Research and Clinical Interventions, 6(1), 1–6.

[12] Cao, Q., Tan, C. C., Xu, W., Hu, H., Cao, X. P., Dong, Q., Tan, L., & Yu, J. T. (2020). The Prevalence of Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease : JAD, 73(3), 1157–1166.

[13] Duboisa, B., Padovanib, A., Scheltensc, P., Rossid, A., & Agnello, G. D. (2015). Timely diagnosis for Alzheimer’s disease: A literature review on benefits and challenges. Journal of Alzheimer’s Disease, 49(3)

[14] Banerjee, D., Muralidharan, A., Hakim Mohammed, A. R., & Malik, B. H. (2020). Neuroimaging in Dementia: A Brief Review. Cureus, 12(Mci), 6–13.

[15] Lee, J. C., Kim, S. J., Hong, S., & Kim, Y. S. (2019). Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. Experimental and Molecular Medicine, 51(5).

[16] Alzheimer’s Association Facts and figures. Alzheimer's Dement 2020;2020:391–460.

[17] Appels, B. A., & Scherder, E. (2010). The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: A systematic review. American Journal of Alzheimer’s Disease and Other Dementias, 25(4), 301–316., 617–631.

[18] Jiao, B., Li, R., Zhou, H., Qing, K., Liu, H., Pan, H., ... & Shen, L. (2023). Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology. Alzheimer's Research & Therapy, 15(1), 32.

[19] Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019). Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity. NPJ digital medicine, 2(1), 9.

[20] Gauthier S, Rosa-Neto P, Morais JA, & Webster C. 2021. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London, England: Alzheimer’s Disease International